Experiment 522279
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | UEDA,T: TOHYAMA,K: WANO,Y: TSUTANI,H: FUKUSHIMA,T: IWASAKI,H: URASAKI,Y: GOTOH,N: KIMURA,S: OKUMURA,E: KAGAWA,D: NAKAMURA,T:. (1994). PHARMACOKINETIC AND CLINICAL PILOT STUDY OF HIGH-DOSE INTERMITTENT UBENIMEX TREATMENT IN PATIENTS WITH MYELODYSPLASTIC SYNDROME.. 14(5B) |
| Amount utilized | |
| Compound isolated | |
| Disease | STUDY OF EFFICACY OF CMPD IN TREATING MYELODYSPLASTIC SYNDROME. EIGHT PATIENTS WERE DOSED TWICE DAILY X 8 WEEKS. TWO PATIENTS HAD PARTIAL RESPONSE. |
| Dose amount | 150.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | PERSON |
| Dose expression | DOSE |